Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (52)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Buhmann, C.
Right arrow Articles by Büchel, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buhmann, C.
Right arrow Articles by Büchel, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 126, No. 2, 451-461, February 2003
© 2003 Guarantors of Brain
doi: 10.1093/brain/awg033

Pharmacologically modulated fMRI---cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients

C. Buhmann, V. Glauche, H. J. Stürenburg, M. Oechsner, C. Weiller and C. Büchel

Department of Neurology, University Hospital of Hamburg, Germany

Correspondence to: Carsten Buhmann MD, Neurologische Universitätsklinik, Haus 510, Universitäts-Krankenhaus Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany E-mail: buhmann{at}uke.uni-hamburg.de

According to the basal ganglia–thalamocortical circuit model, dopamine depletion in the nigrostriatal system leads to hypoactivation in the supplementary motor area (SMA) and the primary motor cortex (M1) in Parkinson’s disease. This functional cortical deafferentation and its reversibility by levodopa (L-dopa) treatment has been established in previous studies for SMA but remains controversial for M1. We used functional MRI (fMRI) and a simple finger opposition task to correlate blood oxygenation level-dependent (BOLD) signal changes with motor performance, assessed separately for each hand between fMRI scanning sessions. Eight drug-naive patients with an akinetic idiopathic hemiparkinsonian syndrome (Hoehn and Yahr stage 1–1.5) and 10 healthy controls were studied. Patients performed a simple, auditory-paced random finger- opposition task every 3 s before and repeatedly every 20 min after intake of 300 mg of fast-release L-dopa. M1 contralateral to the affected hand and SMA, predominantly of the contralateral side, showed a BOLD signal increase after L-dopa intake. Furthermore, comparing BOLD responses of M1 and SMA between the patients and controls revealed that these areas were hypoactive before L-dopa treatment. Signal changes in M1 and SMA were highly correlated with motor performance, which increased after L-dopa intake. This result is not confounded by a performance effect because the motor task employed during scanning was identical throughout all sessions. In contrast to previous imaging studies in which cortical reorganization in Parkinson’s disease was thought to have caused M1 hyperactivation, our data are in accordance with the hypothesis that, in de novo idiopathic hemiparkinsonian syndrome, motor cortex hypoactivation in contralateral M1 and bilateral SMA is caused by a decreased input from the subcortical motor loop, which is reversible by L-dopa.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cereb CortexHome page
A. Suppa, E. Iezzi, A. Conte, D. Belvisi, L. Marsili, N. Modugno, G. Fabbrini, and A. Berardelli
Dopamine Influences Primary Motor Cortex Plasticity and Dorsal Premotor-to-Motor Connectivity in Parkinson's Disease
Cereb Cortex, January 5, 2010; (2010) bhp288v1.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Kelly, G. de Zubicaray, A. Di Martino, D. A. Copland, P. T. Reiss, D. F. Klein, F. X. Castellanos, M. P. Milham, and K. McMahon
L-Dopa Modulates Functional Connectivity in Striatal Cognitive and Motor Networks: A Double-Blind Placebo-Controlled Study
J. Neurosci., June 3, 2009; 29(22): 7364 - 7378.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. Buhmann, F. Binkofski, C. Klein, C. Buchel, T. van Eimeren, C. Erdmann, K. Hedrich, M. Kasten, J. Hagenah, G. Deuschl, et al.
Motor reorganization in asymptomatic carriers of a single mutant Parkin allele: a human model for presymptomatic parkinsonism
Brain, October 1, 2005; 128(10): 2281 - 2290.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
G. M. Halliday, V. Macdonald, and J. M. Henderson
A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease
Brain, October 1, 2005; 128(10): 2272 - 2280.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. Buhmann, A. Gorsler, T. Baumer, U. Hidding, C. Demiralay, K. Hinkelmann, C. Weiller, H. R. Siebner, and A. Munchau
Abnormal excitability of premotor-motor connections in de novo Parkinson's disease
Brain, December 1, 2004; 127(12): 2732 - 2746.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
E. Seiss and P. Praamstra
The basal ganglia and inhibitory mechanisms in response selection: evidence from subliminal priming of motor responses in Parkinson's disease
Brain, February 1, 2004; 127(2): 330 - 339.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.